Seminars in Pediatric Neurology
Volume 14, Issue 1 , Pages 26-33 , March 2007

Trinucleotide Repeat Disorders

  • Richard E. Lutz, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Richard E. Lutz, MD, University of Nebraska Medical Center, Munroe–Meyer Institute for Genetics and Rehabilitation, 985430 Nebraska Medical Center, Omaha, NE 68198-5430.

References 

  1. Everett CM, Wood NW. Trinucleotide repeats in neurodegenerative disease. Brain. 2004;127:2385–2405
  2. Goldberg P. The ups and downs of parting COMPany poly-aspartic acid tract: A novel expansion-contraction mutation. Clinic Genet. 1999;56(4):259–261
  3. van de Warrenburg BB, Sinke RJ, Kremer BJ. Recent advances in hereditary spinocerebellar ataxias. Neuropathol Exp Neurol. 2005;64(3):171–180
  4. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: Mechansims of dynamic mutations. Nat Rev Genet. 2005;6(10):729–742
  5. Sinden RR, Potaman VN, Oussatcheva EA, et al. Triplet repeat DNA structures and human genetic disease: Dynamic mutations from dynamic DNA. J Biosci. 2002;27:53–65
  6. Otto CJ, Almqvist E, Hayden MR, et al. The ‘flap’ endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion Huntington disease. Clin Genet. 2001;59:122–127
  7. Pearson CE, Ewela A, Acharya S, et al. Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases. Hum Mol Genet. 1997;6:1117–1123
  8. Mirken SM. DNA structures, repeat expansions and human hereditary disorders. Curr Opin Struct Biol. 2006;16(3):351–358
  9. Morfini G, Pigino G, Brady ST. Polyglutamine expansion diseases: Failing to deliver. Trends Mol Med. 2005;11(2):64–70
  10. Wells RD, Deere R, Hebert ML, et al. Advances in mechanisms with genetic instability related to hereditary neurological diseases. Nucleic Acids Res. 2005;33(12):3785–3798
  11. Brown LY, Brown SA. Alanine tracts: The expanding story of human illness in trinucleotide repeats. Trends Genet. 2004;20(1):51–58
  12. Schiwach RS, Norbury CJ. A controlled psychiatric study of individuals at risk for Huntington disease. Br J Psychiatry. 1994;165:500–505
  13. Rubinsztein DC, Leggo J, et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A. 1997;94:3872–3876
  14. Katsuno M, Adachih A, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med. 2003;9:768–773
  15. Trochet D, O’Brien L, et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet. 2005;76:421–426
  16. OMIM 164300, Oculopharyngeal Muscular Dystrophy; OPMD, Available at: www.ncvi.nlm.nih.gov/entrez/dispomim.cgi?id=164300.
  17. OMIM 125370, Dentatorubral-Pallidoluysian Atrophy; DRPLA. Available at: http://www.ncvi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=125370.
  18. Bidichandani SI, Shizawa T, Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet. 1998;62(1):111–121
  19. Rustin P, von Kleist-Retzow JC, et al. Effect of idebenone on cardiomyopathy and Friedreich’s ataxia: A preliminary study. Lancet. 1999;354:477–479
  20. Linch DR, Farmer JM, et al. Friedreich ataxia: Effects of genetic understanding on the clinical evaluation and therapy. Arch Neurol. 2002;59:743–747
  21. Ranum LPW, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet. 2004;74:793–804
  22. Jacquemont S, Hagerman RJ, et al. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72:869–878
  23. Blomquist HK, Bohman M, et al. Frequency of Fragile X syndrome in infantile autism (A Swedish multicenter study). Clin Genet. 1985;27:113–117
  24. Schaefer GB, Lutz RE. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med. 2006;8:549–556
  25. Murray A, Ennis S, Morton N. No evidence for parent of origin influencing premature ovarian failure in Fragile X premutation carriers. Am J Hum Genet. 2000;67(1):253–254
  26. Hagerman RJ, Leehy M, et al. Intention tremor, Parkinsonism, and generalized brain atrophy in male carriers of Fragile X. Neurology. 2001;57(1):127–130
  27. Hagerman RJ, Leavitt BR, et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004;74(5):1051–1056
  28. Fu Y-H, Kuhl DPA, et al. Variation of the CGG repeat at the Fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell. 1991;67:1047–1058
  29. Edamura KN, Leornard MR, et al. Role of replication and CpG methylation in Fragile X syndrome CGG deletions in primate cells. Am J Hum Genet. 2005;76(2):302–311
  30. Chiurazzi P, Nari G. Pharmacological reactivation of inactive genes: The Fragile X experience. Brain Res Bull. 2001;56:383–387
  31. Bird TD: Hereditary ataxia overview. Available at: www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=zDedSYuboePLe&gry=&fn=y&fw=Jxyq&filename=/profiles/ataxias/index.html.
  32. Nance MA. Clinical aspects of CAG repeat disease. Brain Pathol. 1997;7:881–900
  33. Alfen N, Sinke RJ, et al. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol. 2001;49:805–808
  34. Yvert G, Lindenberg KS, et al. Expanded polyglutamines induced neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum Molec Genet. 2000;9:2491–2506
  35. Cholfin JA, Soprido MJ, et al. The SCA12 mutation as a rare cause of spinocerebellar ataxia. Arch Neurol. 2001;58:1833–1835

PII: S1071-9091(06)00163-X

doi: 10.1016/j.spen.2006.11.006

Seminars in Pediatric Neurology
Volume 14, Issue 1 , Pages 26-33 , March 2007

Article Tools